首页> 美国卫生研究院文献>Springer Open Choice >Retrospective analysis of the use of G-CSF and its impact on dose response for anthracycline plus taxane-based schedules in early breast cancer

【2h】

Retrospective analysis of the use of G-CSF and its impact on dose response for anthracycline plus taxane-based schedules in early breast cancer

机译：回顾性分析G-CSF的使用及其对蒽环类药物和紫杉烷类药物治疗早期乳腺癌剂量反应的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeTo evaluate the impact on survival of the relative dose intensity (RDI) achieved in patients with early breast cancer receiving anthracycline plus taxane-based chemotherapy in the adjuvant setting.

机译：目的评估在辅助环境中接受蒽环类药物加紫杉烷类化学疗法治疗的早期乳腺癌患者对相对剂量强度（RDI）存活的影响。

著录项

期刊名称 Springer Open Choice
作者
J. A. Pérez-Fidalgo; B. Bermejo; I. Chirivella; M. T. Martínez; I. González; J. M. Cejalvo; I. Catoira; P. Martínez; E. Contel; A. Lluch;
展开▼
作者单位

展开▼
年(卷),期 -1(16),9
年度 -1
页码 814–822
总页数 9
原文格式 PDF
正文语种
中图分类外科学;
关键词
Anthracyclines Early breast cancer Granulocyte colony-stimulating factor Observational study Taxanes;

机译：蒽环类药物;早期乳腺癌;粒细胞集落刺激因子;观察研究;紫杉烷类;

相似文献

外文文献
中文文献
专利

1. Retrospective analysis of the use of G-CSF and its impact on dose response for anthracycline plus taxane-based schedules in early breast cancer [J] . Pérez-FidalgoJ.A., BermejoB., ChirivellaI., Clinical & translational oncology : . 2014,第9期

机译：对G-CSF使用的回顾性分析及其对早期乳腺癌中蒽环类紫杉烷的时间响应的影响
2. Retrospective analysis of the impact of anthracycline dose reduction and chemotherapy delays on the outcomes of early breast cancer molecular subtypes [J] . Sigita Liutkauskiene, Saulius Grizas, Kristina Jureniene, BMC Cancer . 2018,第1期

机译：蒽环类药物减量和化疗延迟对早期乳腺癌分子亚型结局的影响的回顾性分析
3. Retrospective analysis of the impact of anthracycline dose reduction and chemotherapy delays on the outcomes of early breast cancer molecular subtypes [J] . Sigita Liutkauskiene, Saulius Grizas, Kristina Jureniene, BMC Cancer . 2018,第1期

机译：蒽环类药物减量和化疗延迟对早期乳腺癌分子亚型结局的影响的回顾性分析
4. Clinical implications of HER-2 and p53 in taxane-based and anthracycline-based neoadjuvant chemotherapy in breast cancer [C] . World congress on breast diseases . 2008

机译：HER-2和P53在紫杉烷基和蒽环类新辅助化疗的乳腺癌中的临床意义
5. The genomic response of MCF-7 breast cancer cells in the selection of resistance to taxane and anthracycline chemotherapeutics. [D] . Veitch, Zachary William Neil. 2007

机译：MCF-7乳腺癌细胞在对紫杉烷和蒽环类药物的耐药性选择中的基因组反应。
6. Optimal radiation dose for patients with one to three lymph node positive breast cancer following breast-conserving surgery and anthracycline plus taxane-based chemotherapy: A retrospective multicenter analysis (KROG 1418) [O] . Haeyoung Kim, Won Park, Jeong Il Yu, 2017

机译：保乳手术和蒽环类药物加紫杉烷类化疗后1-3例淋巴结阳性乳腺癌患者的最佳放射剂量：回顾性多中心分析（KROG 1418）
7. Retrospective analysis of the use of G-CSF and its impact on dose response for anthracycline plus taxane-based schedules in early breast cancer [O] . 2014

机译：回顾性分析G-CSF的使用及其对蒽环类药物和紫杉烷类药物治疗早期乳腺癌剂量反应的影响

Retrospective analysis of the use of G-CSF and its impact on dose response for anthracycline plus taxane-based schedules in early breast cancer

摘要

著录项

相似文献

相关主题

期刊订阅